Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase

Abstract

Recently, hydrogen sulfide (H2S) has been identified as a potential therapy for ED. However, a thorough understanding of its molecular mechanisms of action would be essential to develop H2S as a new therapy for ED. In this study, the effect of H2S on nitric oxide (NO) production, especially through the expression of constitutive nitric oxide synthase (NOS) isoforms—endothelial NOS (eNOS) and neuronal NOS (nNOS) in rat corpus cavernosum (CC) were explored. Real-time PCR studies subsequent to in vitro treatment of sodium hydrosulfide hydrate (NaHS), a stable H2S donor, showed increases in eNOS but not nNOS mRNA. Western blot studies confirmed that the exogenously applied NaHS increased eNOS but not nNOS protein expression in the rat CC. Furthermore, NaHS did not alter the expressed amounts of Caveolin-1 (CAV-1), a dominant inhibitory interaction partner of eNOS, in these tissues. Not surprisingly, NaHS also enhanced the NO production in eNOS-associated membrane fraction of rat CC. Taken together, we ascertain that H2S could exert its proerectile effects by augmenting NO pathway. It appears that H2S would be particularly useful in improving the clinical outcome of ED patients, whose erectile impairment is due to an inherent attenuation of the endothelial NO formation in the cavernosum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Li L, Moore PK . Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 2008; 29: 84–90.

    Article  Google Scholar 

  2. Wang R . Hydrogen sulfide: a new EDRF. Kidney Int 2009; 76: 700–704.

    Article  CAS  Google Scholar 

  3. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587–590.

    Article  CAS  Google Scholar 

  4. Yang G, Wu L, Wang R . Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 2006; 20: 553–555.

    Article  CAS  Google Scholar 

  5. Zhao W, Zhang J, Lu Y, Wang R . The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008–6016.

    Article  CAS  Google Scholar 

  6. Srilatha B, Adaikan PG, Moore PK . Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction—a pilot study. Eur J Pharmacol 2006; 535: 280–282.

    Article  CAS  Google Scholar 

  7. d’Emmanuele di Villa Bianca R, Sorrentino R, Maffia P, Mirone V, Imbimbo C, Fusco F et al. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci USA 2009; 106: 4513–4518.

    Article  Google Scholar 

  8. Srilatha B, Adaikan PG, Li L, Moore PK . Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J Sex Med 2007; 4: 1304–1311.

    Article  CAS  Google Scholar 

  9. Tang G, Wu L, Liang W, Wang R . Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 2005; 68: 1757–1764.

    CAS  PubMed  Google Scholar 

  10. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 2009; 106: 21972–21977.

    Article  CAS  Google Scholar 

  11. Duran WN, Breslin JW, Sanchez FA . The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res 2010; 87: 254–261.

    Article  CAS  Google Scholar 

  12. Toda N, Ayajiki K, Okamura T . Nitric oxide and penile erectile function. Pharmacol Ther 2005; 106: 233–266.

    Article  CAS  Google Scholar 

  13. Palit V, Eardley I . An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat Rev Urol 2010; 7: 603–609.

    Article  CAS  Google Scholar 

  14. Burnett AL . Erectile dysfunction. J Urol 2006; 175 (3 Pt 2): S25–S31.

    PubMed  Google Scholar 

  15. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK . The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 2010; 12: 1147–1154.

    Article  CAS  Google Scholar 

  16. Ghigo D, Riganti C, Gazzano E, Costamagna C, Bosia A . Cycling of NADPH by glucose 6-phosphate dehydrogenase optimizes the spectrophotometric assay of nitric oxide synthase activity in cell lysates. Nitric Oxide 2006; 15: 148–153.

    Article  CAS  Google Scholar 

  17. Parat MO, Fox PL . Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. J Biol Chem 2001; 276: 15776–15782.

    Article  CAS  Google Scholar 

  18. Michel JB, Feron O, Sase K, Prabhakar P, Michel T . Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997; 272: 25907–25912.

    Article  CAS  Google Scholar 

  19. Chitaley K, Kupelian V, Subak L, Wessells H . Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol 2009; 182 (6 Suppl): S45–S50.

    PubMed  PubMed Central  Google Scholar 

  20. Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A et al. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003; 312: 1202–1208.

    Article  CAS  Google Scholar 

  21. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC et al. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2004; 101: 9121–9126.

    Article  CAS  Google Scholar 

  22. Bivalacqua TJ, Musicki B, Usta MF, Champion HC, Kadowitz PJ, Burnett AL et al. Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des 2005; 11: 4059–4067.

    Article  CAS  Google Scholar 

  23. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC . The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007; 76: 29–40.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the award of the research grant R-174-000-128-213 by the National Medical Research Council, Ministry of Health, Singapore for the conduct of this work. The technical assistance provided by Ms Roeswita Leono Liaw is duly appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Srilatha.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on International Journal of Impotence Research website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meng, J., Ganesan Adaikan, P. & Srilatha, B. Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase. Int J Impot Res 25, 86–90 (2013). https://doi.org/10.1038/ijir.2012.39

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2012.39

Keywords

This article is cited by

Search

Quick links